The role of molecular testing and enzyme analysis in the management of hypomorphic citrullinemia
- 27 October 2008
- journal article
- case report
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 146A (22), 2885-2890
- https://doi.org/10.1002/ajmg.a.32527
Abstract
Expanded newborn screening detects patients with modest elevations in citrulline; however it is currently unclear how to treat these patients and how to counsel their parents. In order to begin to address these issues, we compared the clinical, biochemical, and molecular features of 10 patients with mildly elevated citrulline levels. Three patients presented with clinical illness whereas seven came to attention as a result of expanded newborn screening. One patient presented during pregnancy and responded promptly to IV sodium phenylacetate/sodium benzoate and arginine therapy with no long‐term adverse effects on mother or fetus. Two children presented with neurocognitive dysfunction, one of these responded dramatically to dietary protein reduction. ASS enzyme activity was not deficient in all patients with biallelic mutations suggesting this test cannot exclude the ASS1 locus in patients with mildly elevated plasma citrulline. Conversely, all symptomatic patients who were tested had deficient activity. We describe four unreported mutations (p.Y291S, p.R272H, p.F72L, and p.L88I), as well as the common p.W179R mutation. In silico algorithms were inconsistent in predicting the pathogenicity of mutations. The cognitive benefit in one patient of protein restriction and the lack of adverse outcome in seven others restricted from birth, suggest a role for protein restriction and continued monitoring to prevent neurocognitive dysfunction.Keywords
This publication has 22 references indexed in Scilit:
- Utility of Oligonucleotide Array–Based Comparative Genomic Hybridization for Detection of Target Gene DeletionsClinical Chemistry, 2008
- Predicting the Effects of Amino Acid Substitutions on Protein FunctionAnnual Review of Genomics and Human Genetics, 2006
- Postpartum “Psychosis” in Mild Argininosuccinate Synthetase DeficiencyObstetrics & Gynecology, 2005
- A pregnant patient with fulminant hepatic failure was found to carry a novel missense mutation in the argininosuccinate synthetase geneThe Esophagus, 2004
- In Silico Prediction of the Deleterious Effect of a Mutation: Proceed with Caution in Clinical GeneticsClinical Chemistry, 2004
- Pregnancy in a healthy woman with untreated citrullinemiaAmerican Journal of Medical Genetics Part A, 2004
- Long-term outcome of patients with urea cycle disorders and the question of neonatal screeningEuropean Journal of Pediatrics, 2003
- Mild citrullinemia in Caucasians is an allelic variant of argininosuccinate synthetase deficiency (citrullinemia type 1)Molecular Genetics and Metabolism, 2003
- Variants of citrullinaemia.Archives of Disease in Childhood, 1973
- CITRULLINURIA A NEW AMINOACIDURIA ASSOCIATED WITH MENTAL RETARDATIONThe Lancet, 1962